NIH-funded research NIH-funded research

Identifying who will develop long-lasting headaches after a concussion

Official title: Biomarker Signature to Predict the Persistence of Post-Traumatic Headache

Funded at Mayo Clinic Arizona · NIH-10897709 · Data updated 2026-11-12

This study is looking to find a way to predict which people might have long-lasting headaches after a concussion, so that doctors can start the right treatment sooner and help them feel better faster.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMayo Clinic Arizona
NIH-funded
Lab location1 site (Scottsdale, United States)
Project startSeptember 1, 2019
Project endJuly 31, 2025
Funding year2024
Award (this year)$1,038,506
NIH project number5R33NS113315-03
Project IDNIH-10897709 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have recently experienced a concussion and are suffering from acute post-traumatic headache.

Less likely to help

Patients who have not experienced a concussion or those with chronic headache conditions unrelated to trauma may not benefit from this research.

What this research studies

This research aims to develop a biomarker signature that can predict which patients will experience persistent post-traumatic headache (PPTH) following a concussion. By analyzing clinical data and brain imaging, the study seeks to identify individuals at high risk for PPTH during the acute phase of their injury. This early identification could enable healthcare providers to initiate appropriate treatment sooner, potentially improving patient outcomes. The goal is to enhance decision-making for clinicians managing patients with acute post-traumatic headache.

Why it matters

Potential benefit: If successful, this research could lead to more effective early treatments for patients at risk of developing persistent headaches after a concussion.

How similar studies have gone: Previous research has shown promise in using biomarkers for predicting headache outcomes, but this specific approach is novel and untested.

Where this research is happening

  • Mayo Clinic Arizona
    Scottsdale, United States
    Active

Researchers

  • Principal investigator: Chong, Catherine Daniela — Mayo Clinic Arizona
  • Study coordinator: Chong, Catherine Daniela

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.